<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=384506&amp;fmt=gif">
Skip to content
    April 19, 2024

    CDD Appoints Yasushi Hamagashira as Head of Sales and Marketing for Japan

    Tokyo, Japan, April 16, 2024 — In a significant move to bolster CDD Vault’s presence in the Japanese
    market, Collaborative Drug Discovery (CDD) is excited to announce the appointment of Mr.
    Yasushi Hamagashira as the new Head of Sales and Marketing for Japan. Bringing on board a
    wealth of experience and expertise, Mr. Hamagashira is set to play a pivotal role in CDD’s
    strategic expansion and deepening of client engagements in Japan.

    With a career that spans over two decades in sales management and business development,
    Mr. Hamagashira’s appointment marks a milestone in CDD’s efforts to strengthen its operations
    and outreach in the highly competitive Japanese market. His understanding of market dynamics
    is expected to drive significant growth and innovation in CDD’s sales strategies and customer
    service excellence.

    “Mr. Hamagashira’s joining our team is a clear reflection of CDD’s commitment to investing in
    the best talent to drive our growth,” said Dr. Barry Bunin, founder and CEO of CDD. “We are
    confident that his leadership will be instrumental in our continued growth and success in Japan.”

    Dr. Mariana Vaschetto, Head of International Operations at CDD, also commented on the new
    appointment, “Mr. Hamagashira’s deep market insight and impressive track record align
    perfectly with our strategic goals in Japan. I am enthusiastic about the fresh perspectives and
    dynamic approaches he brings to our team. Together, we are set to provide excellence in
    customer engagement and innovation in the Japanese market.”

    Expressing his eagerness to contribute to CDD’s mission, Mr. Hamagashira shared, “I am
    deeply honored to join the CDD family and take on the challenge of leading the sales operations
    in Japan. The opportunity to drive growth and foster strong client relationships in such a vibrant
    market is incredibly motivating. I am committed to leveraging my experience to propel CDD to
    new heights.”

    Under Mr. Hamagashira’s guidance, CDD is poised to enhance its sales infrastructure and
    operational excellence in Japan, reaffirming its dedication to delivering superior technology
    solutions and services to its clients.

    About Collaborative Drug Discovery

    CDD’s (www.collaborativedrug.com) flagship product, “CDD Vault®” is used to manage
    chemical registration, structure-activity relationships (SAR), and securely scale collaborations.
    CDD Vault® is a hosted database solution for secure management and sharing of biological and
    chemical data. It lets you intuitively organize chemical structures and biological study data, and
    collaborate with internal or external partners through an easy to use web interface. Available
    modules within CDD Vault include Activity &amp; Registration, Visualization, Inventory, and ELN.

    Tag(s): CDD Blog , News

    Other posts you might be interested in

    View All Posts
    CDD Blog
    3 min   May 18, 2024
    Upcoming Webinar: Targeted Protein Degradation - New Modalities and Design Technologies
    Read More
    CDD Vault Updates
    4 min   May 17, 2024
    CDD Vault Update (May 2024 #2): View Assay Ontologies, SureChEMBL Deep Learning Similarity Search, Merge/Split ELN Table Cells, File Previews in ELN
    Read More
    CDD Vault Updates
    8 min   May 10, 2024
    CDD Vault Update (May 2024): Overlay & Customize Dose-Response Plots, Bioisosteric Compound Suggestions, Parser Updates, and Quickly Search Related Protocols
    Read More